SynthesisJournal of managed care & specialty pharmacy2016

A Systematic Review of PCSK9 Inhibitors Alirocumab and Evolocumab.

Marian McDonagh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.